Hope to Launch COVOVAX by June 2021: SII CEO Adar Poonawalla

Pune: The Serum Institute of India (SII) is hopeful of launching another COVID-19 vaccine ‘COVOVAX’ by June this year.

“Our partnership for a COVID-19 vaccine with Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch COVOVAX by June 2021”, said SII CEO Adar Poonawalla.

After rolling out COVISHIELD vaccine, the SII has applied to India’s drugs controller for permission to conduct small domestic trial in India for Novavax’s Coronavirus disease (Covid-19) vaccine candidate ‘COVOVAX’.

The vaccine was found to be 89.3% effective in a UK trial and was nearly as effective in protecting against the more highly contagious variant first discovered in Britain, according to reports.

Comments are closed.